Established to study the genetic causes and origins of common cancers (e.g. breast, melanoma, colon, and prostate) and to develop DNA based diagnostics. Focus is on developing approaches to gene mapping and gene isolation for future applications in cancer diagnosis and therapy.

Cancer Genetic Epidemiology 90-91
Cancer Genetic Epidemiology 91-92
Cancer Genetic Epidemiology 92-93
Cancer Genetic Epidemiology 93-94
Cancer Genetic Epidemiology 94-95

Highlights

• The Center has cloned the 17q linked breast cancer gene and the 9p linked melanoma gene.
• Myriad Genetics employes 770 people with revenues of approximately $100MM

Spin Out Companies

• Myriad Genetics

Benefiting Companies

Center's University Website and Contact Information